To view this email as a web page, click here.
June 22, 2017
 
ADVERTISEMENT
 
PHARMACISTS' REPORT
 
Fighting Opioid Misuse: The Numbers
So just how much naloxone is getting out? How many pharmacies are using EPCS?
Read more
 
ADVERTISEMENT
Advertisement
Specialty Drugs: Unintended Consequences May Slow the Market
Report looks at possible impediments to growth in the specialty market, including patient access.
Read more
 
The Case for Indications on Prescriptions
Putting indications on all prescriptions may reduce errors.
Read more
 
CE: Heart failure: Pumping up Knowledge, Circulating New Approaches
What you need to know about new guidelines to help drive management of heart failure with reduced ejection fraction (HFrEF).
Read more
 
 
ADVERTISEMENT
Leave your staff, patients, and legacy in good hands.
Selling your pharmacy comes with tough questions and big decisions. Make sure your goals are met and get answers to 5 of the most common questions for those who may be selling their pharmacy.

Read this Partner Perspectives to learn more. »
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.